February 1 Research Roundup: Alzheimer’s, Gum Disease and Gut Bacteria, New Understanding of Cholesterol, Pancreatic Cancer and More 글 내용 전체보기
Q4 Biopharma Themes: Strong 2018, Weaker 2019 Earnings Projections, Concerns Over Drug Pricing 글 내용 전체보기
Sylentis announces results of Phase 3 HELIX trial with tivanisiran for the treatment of Dry Eye Disease 글 내용 전체보기
Oxycodone Market: Increasing Prevalence of Chronic Diseases and Trauma Conditions Likely to Boost Industry Growth 글 내용 전체보기